BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8507808)

  • 1. Angiotensin II as a renal growth factor.
    Wolf G; Neilson EG
    J Am Soc Nephrol; 1993 Mar; 3(9):1531-40. PubMed ID: 8507808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin as a renal growth promoting factor.
    Wolf G
    Adv Exp Med Biol; 1995; 377():225-36. PubMed ID: 7484425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
    Wolf G
    Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of intrarenally generated angiotensin II on renal hemodynamics and tubular reabsorption.
    Mitchell KD; Navar LG
    Ren Physiol Biochem; 1991; 14(4-5):155-63. PubMed ID: 1708902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal injury from angiotensin II-mediated hypertension.
    Johnson RJ; Alpers CE; Yoshimura A; Lombardi D; Pritzl P; Floege J; Schwartz SM
    Hypertension; 1992 May; 19(5):464-74. PubMed ID: 1568765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
    Cervenka L; Wang CT; Mitchell KD; Navar LG
    Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells.
    Wolf G; Ziyadeh FN; Stahl RA
    J Mol Med (Berl); 1999 Jul; 77(7):556-64. PubMed ID: 10494801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin II in diabetic nephropathy.
    Leehey DJ; Singh AK; Alavi N; Singh R
    Kidney Int Suppl; 2000 Sep; 77():S93-8. PubMed ID: 10997697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic intrarenal actions of angiotensin on tubular reabsorption and renal hemodynamics.
    Navar LG; Saccomani G; Mitchell KD
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):90-6. PubMed ID: 2007003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal responses to AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Cervenka L; Mitchell KD
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):45S-54S. PubMed ID: 10678288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.
    Yang S; Yao B; Zhou Y; Yin H; Zhang MZ; Harris RC
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F742-9. PubMed ID: 22169008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamic and tubular effects of angiotensins II and III.
    Huang WC
    Chin J Physiol; 1991; 34(1):121-38. PubMed ID: 1874031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells.
    Wolf G; Wenzel U; Jablonski K; Brundert M; Rinninger F
    Nephrol Dial Transplant; 2005 Jun; 20(6):1222-7. PubMed ID: 15894808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
    Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
    Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
    Su Z; Zimpelmann J; Burns KD
    Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubular hypertrophy induced by angiotensin II.
    Wolf G; Ziyadeh FN
    Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
    Wolf G; Ritz E
    Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth.
    Gómez-Garre D; Ruiz-Ortega M; Ortego M; Largo R; López-Armada MJ; Plaza JJ; González E; Egido J
    Hypertension; 1996 Apr; 27(4):885-92. PubMed ID: 8613264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.